Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

GeoVax Labs (GOVX) EBITDA Margin (2016 - 2025)

GeoVax Labs' EBITDA Margin history spans 15 years, with the latest figure at 635.81% for Q2 2025.

  • Quarterly results put EBITDA Margin at 635.81% for Q2 2025, up 104780.0% from a year ago — trailing twelve months through Dec 2025 was 869.34% (down 23351.0% YoY), and the annual figure for FY2025 was 869.34%, down 23351.0%.
  • EBITDA Margin for Q2 2025 was 635.81% at GeoVax Labs, down from 330.22% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 209.88% in Q3 2024 to a low of 8331.46% in Q4 2021.
  • The 4-year median for EBITDA Margin is 1550.06% (2021), against an average of 2483.22%.
  • The sharpest move saw EBITDA Margin crashed -780007bps in 2021, then surged 104780bps in 2025.
  • Year by year, EBITDA Margin stood at 8331.46% in 2021, then surged by 64bps to 2978.24% in 2022, then surged by 68bps to 965.32% in 2024, then soared by 34bps to 635.81% in 2025.
  • According to Business Quant data, EBITDA Margin over the past three periods came in at 635.81%, 330.22%, and 965.32% for Q2 2025, Q1 2025, and Q4 2024 respectively.